Summary
The hypothesis was tested that islet autoimmunity is induced by ongoing islet cell destruction in subjects with susceptibility genes HLA-DR 3 and/or DR 4. Sixty-one patients with confirmed chronic pancreatitis were analysed, 30 of whom expressed HLA-DR 3 and/or DR 4. Electron microscopy studies in 10 patients showed that the inflammatory process also affected islets, as recognisable from islet cell lysis, intrainsular fibrosis and immune cell infiltrates. None of the sera tested contained any of three markers of islet autoimmunity, ICA, IAA or GAD antibodies. A correlation was seen between the loss of exocrine function, as determined by the ALTAB-test, and of beta-cell function, as determined by the C-peptide response to i.v. glucagon. However, there was no preferential loss of beta-cell function in patients with HLA-DR 3 and/or DR 4. We conclude that islet cell destruction occurs during chronic pancreatitis, but does not trigger islet autoimmunity, even in the presence of HLA-DR 3 and/or DR 4.
Article PDF
Similar content being viewed by others
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- ICA:
-
islet cell antibodies
- IAA:
-
insulin autoantibodies
- GAD:
-
glutamate decarboxylase
- JDF:
-
Juvenile Diabetes Foundation
- PAB A:
-
N-acetyl-L-tyrosyl-paraaminobenzoic acid
References
Pujol-Borrell R, Todd I, Doshi M, Gray D, Feldmann M, Bottazzo GF (1986) Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol. 65: 128–139
Forbes A, Schwarz G, Mirakian Ret al. (1987) HLA antigens in chronic pancreatitis. Tissue Antigens 30: 176–183
Domschke S, Stock KP, Pichl J, Schneider MU, Domschke W (1985) Beta-cell reserve capacity in chronic pancreatitis. He-patogastroenterology 32: 27–30
Amman RW, Buehler H, Muench R, Freiburghaus AW, Siegenthaler W (1987) Differences in the natural history of idiopathic (non-alcoholic) and alcoholic chronic pancreatitis. A comparative long-term study of 287 patients. Pancreas 2: 368–377
Bonora E, Rizzi C, Lesi C, Berra P, Coscelli C, Butturini U (1988) Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia. Dig Dis Sci 33: 732–736
Sheehy MJ (1992) HLA and insulin-dependent diabetes: a protective perspective. Diabetes 41: 123–129
Ziegler R, Alper CA, Awdeh ZL et al. (1991) Specific association of HLA-DR4 with increased prevalence and lEVel of insulin autoantibodies in first-degree relatives of patients with IDDM. Diabetes 40: 709–714
Ziegler AG, Standl E, Albert E, Mehnert H (1991) HLA-as-sociated insulin autoantibody formation in newly diagnosed IDDM patients. Diabetes 40: 1146–1149
Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H (1989) Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 32: 126–134
Kolb H, Dannehl K, Griinklee D et al. (1988) Prospective analysis of islet cell antibodies in children with IDDM. Diabetologia 31: 189–194
Lernmark A, Molenaar JL, van Beers WAM et al. (1991) The Fourth International Serum Exchange Workshop to standardise cytoplasmic islet cell antibodies. Diabetologia 34: 534–535
Greenbaum C, Palmer JP, Kuglin B, Kolb H (1992) Insulin autoantibodies measured by RIA methodology are more re lated to IDDM than those measured by ELISA. J Clin Endocrinol Metab 74:1040–1044
Christie MR, Brown TJ, Cassidy D (1992) Binding of antibodies in sera from IDDM patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and nonantigenic forms of the enzyme. Diabetologia 35:380–384
Henker J, Sprossig C (1988) Specificity and sensitivity of the 4-N-acetyl-L-tyrosyl-p-aminobenzoic acid test in childhood with serum p-aminobenzoic acid determination. Dtsch Z Verdau Stoffwechselkr 48:80–82
Terasaki PI, McClelland JD (1964) Microdroplet assay of human serum lymphocytotoxins. Nature 204:990–1000
Gyr K, Heitz U, Beglinger C (1984) Pancreatitis. In: Kloppel G, Heitz PU, Gepts W (eds) Pancreatic pathology. Churchill Livingstone, Edinburgh London Melbourne New York, pp 44–72
Rageh W, Klugmann HJ, Schiedewitz W, Pohl A (1985) Der modifizierte ALTAB-Test in der Diagnostik der exokrinen Pankreasinsuffizienz. Dtsch Z Verdau Stoffwechselkr 45: 307–316
Bovo P, Mirakian R, Merigo F et al. (1987) HLA molecule expression on chronic pancreatitis specimens: Is there a role for autoimmunity? A preliminary study. Pancreas 2:350–356
Larsen S, Hilsted J, Jakobsen BK, Svejgaard A, Marner B, Worning H (1990) Insulin-dependent diabetes mellitus secondary to chronic pancreatitis is not associated with HLA or the occurrence of islet-cell antibodies. J Immunogenet 17: 189–193
Marner B, Bille G, Christy M et al. (1991) Islet cell cytoplasmic antibodies (ICA) in diabetes and disorders of glucose tolerance. Diabetic Med 8:812–816
Nigro G (1991) Pancreatitis with hypoglycemia-associated convulsions following rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 12:280–282
Ludvigsson J, Forsberg P, Fryden A, Lindblom B, Marshall MO, nvonSchenck H (1988) Mumps with laboratory signs of subclinical pancreatitis may cause a disturbed beta-cell function. Diabetes Res 9:193–195
Helmke K, Otten A, Willems WR et al. (1986) Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 29: 30–33
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lampeter, E.F., Kolb, H., Seifert, I. et al. Inflammatory islet damage in patients bearing HLA-DR 3 and/or DR 4 haplotypes does not lead to islet autoimmunity. Diabetologia 37, 471–475 (1994). https://doi.org/10.1007/s001250050134
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050134